BlackRock, Inc. Reduces Stake in RxSight, Inc.

BlackRock, Inc. has filed a Schedule 13G/A with the SEC, disclosing a reduction in its stake in RxSight, Inc. As of September 30, 2025, BlackRock owns 2,393,289 shares of RxSight's common stock, representing a 5.8% ownership stake. This marks a decrease of 613,821 shares from its previous holdings, reflecting a 20.41% reduction in shares and a 49.55% decrease in the value of its holdings. The filing indicates that BlackRock acquired and holds these securities in the ordinary course of business and not for the purpose of influencing the control of RxSight. The filing also includes certifications and exhibits, such as a Power of Attorney and details on subsidiary identification.